Immediate Impact

4 by Nobel laureates 5 from Science/Nature 63 standout
Sub-graph 1 of 23

Citing Papers

Treatment of Highly Drug-Resistant Pulmonary Tuberculosis
2020 Standout
Dolutegravir-Based or Low-Dose Efavirenz–Based Regimen for the Treatment of HIV-1
2019 Standout
2 intermediate papers

Works of Brian Gazzard being referenced

TRIZAL study: switching from successful HAART to TrizivirTM (abacavir‐lamivudine‐zidovudine combination tablet): 48 weeks efficacy, safety and adherence results
2003
Investigation and control of a large outbreak of multi-drug resistant tuberculosis at a central Lisbon hospital
2001

Author Peers

Author Last Decade Papers Cites
Brian Gazzard 474 331 188 221 36 782
Annette Haberl 486 280 150 298 55 846
Jessica L. Castilho 479 210 354 238 38 726
John P. Bennett 216 206 149 167 41 964
Fabrizio Soscia 517 337 120 212 16 766
Jacques Gilquin 435 419 393 307 33 939
George Perez 407 169 140 343 35 765
Selvamuthu Poongulali 449 210 122 198 46 673
Jesús Santos 550 377 351 217 54 844
Mervyn Tyrer 659 493 142 225 27 808
Gerd Fätkenheuer 574 529 191 206 38 898

All Works

Loading papers...

Rankless by CCL
2026